192 related articles for article (PubMed ID: 37713444)
1. Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants.
Sahu S; Sullivan TL; Mitrophanov AY; Galloux M; Nousome D; Southon E; Caylor D; Mishra AP; Evans CN; Clapp ME; Burkett S; Malys T; Chari R; Biswas K; Sharan SK
PLoS Genet; 2023 Sep; 19(9):e1010940. PubMed ID: 37713444
[TBL] [Abstract][Full Text] [Related]
2. Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants.
Huang H; Hu C; Na J; Hart SN; Gnanaolivu RD; Abozaid M; Rao T; Tecleab YA; Pesaran T; Lyra PCM; Karam R; Yadav S; Domchek SM; de la Hoya M; Robson M; Mehine M; Bandlamudi C; Mandelker D; Monteiro ANA; Boddicker N; Chen W; Richardson ME; Couch FJ
bioRxiv; 2023 Dec; ():. PubMed ID: 38168194
[TBL] [Abstract][Full Text] [Related]
3. Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes.
Billaud A; Chevalier LM; Augereau P; Frenel JS; Passot C; Campone M; Morel A
Genome Med; 2021 Nov; 13(1):174. PubMed ID: 34749799
[TBL] [Abstract][Full Text] [Related]
4. Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots".
Dines JN; Shirts BH; Slavin TP; Walsh T; King MC; Fowler DM; Pritchard CC
Genet Med; 2020 May; 22(5):825-830. PubMed ID: 31911673
[TBL] [Abstract][Full Text] [Related]
5. Sequencing-based functional assays for classification of BRCA2 variants in mouse ESCs.
Biswas K; Mitrophanov AY; Sahu S; Sullivan T; Southon E; Nousome D; Reid S; Narula S; Smolen J; Sengupta T; Riedel-Topper M; Kapoor M; Babbar A; Stauffer S; Cleveland L; Tandon M; Malys T; Sharan SK
Cell Rep Methods; 2023 Nov; 3(11):100628. PubMed ID: 37922907
[TBL] [Abstract][Full Text] [Related]
6. DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment.
Toland AE; Andreassen PR
J Med Genet; 2017 Nov; 54(11):721-731. PubMed ID: 28866612
[TBL] [Abstract][Full Text] [Related]
7. Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
Ricks-Santi L; McDonald JT; Gold B; Dean M; Thompson N; Abbas M; Wilson B; Kanaan Y; Naab TJ; Dunston G
Ethn Dis; 2017; 27(2):169-178. PubMed ID: 28439188
[TBL] [Abstract][Full Text] [Related]
8. Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study.
Kim JH; Park S; Park HS; Park JS; Lee ST; Kim SW; Lee JW; Lee MH; Park SK; Noh WC; Choi DH; Han W; Jung SH
Sci Rep; 2021 Apr; 11(1):8485. PubMed ID: 33875706
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological and ES cell-based functional evaluation of BRCA2 variants identified in families with breast cancer.
Sullivan T; Thirthagiri E; Chong CE; Stauffer S; Reid S; Southon E; Hassan T; Ravichandran A; Wijaya E; Lim J; Taib NAM; Fadzli F; Yip CH; Hartman M; Li J; van Dam RM; North SL; Das R; Easton DF; Biswas K; Teo SH; Sharan SK; ;
Hum Mutat; 2021 Feb; 42(2):200-212. PubMed ID: 33314489
[TBL] [Abstract][Full Text] [Related]
10. Reclassification of
Lee JS; Oh S; Park SK; Lee MH; Lee JW; Kim SW; Son BH; Noh DY; Lee JE; Park HL; Kim MJ; Cho SI; Lee YK; Park SS; Seong MW
J Med Genet; 2018 Dec; 55(12):794-802. PubMed ID: 30415210
[TBL] [Abstract][Full Text] [Related]
11. Functional Categorization of
Bouwman P; van der Heijden I; van der Gulden H; de Bruijn R; Braspenning ME; Moghadasi S; Wessels LFA; ; Vreeswijk MPG; Jonkers J
Clin Cancer Res; 2020 Sep; 26(17):4559-4568. PubMed ID: 32546644
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models.
Hart SN; Hoskin T; Shimelis H; Moore RM; Feng B; Thomas A; Lindor NM; Polley EC; Goldgar DE; Iversen E; Monteiro ANA; Suman VJ; Couch FJ
Genet Med; 2019 Jan; 21(1):71-80. PubMed ID: 29884841
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort.
Liu Y; Wang H; Wang X; Liu J; Li J; Wang X; Zhang Y; Bai Z; Zhou Q; Wu Y; Shen Y; Weng X; Liu F; Guo J; Di L; Gires O; Zhang Z; Chen Y; Wang H
J Hematol Oncol; 2021 Jan; 14(1):18. PubMed ID: 33461583
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
15. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
[TBL] [Abstract][Full Text] [Related]
16. Functional evaluation of five BRCA2 unclassified variants identified in a Sri Lankan cohort with inherited cancer syndromes using a mouse embryonic stem cell-based assay.
Sirisena N; Biswas K; Sullivan T; Stauffer S; Cleveland L; Southon E; Dissanayake VHW; Sharan SK
Breast Cancer Res; 2020 May; 22(1):43. PubMed ID: 32393398
[TBL] [Abstract][Full Text] [Related]
17. Characterization of BRCA2 R3052Q variant in mice supports its functional impact as a low-risk variant.
Mishra AP; Hartford S; Chittela RK; Sahu S; Kharat SS; Alvaro-Aranda L; Contreras-Perez A; Sullivan T; Martin BK; Albaugh M; Southon E; Burkett S; Karim B; Carreira A; Tessarollo L; Sharan SK
Cell Death Dis; 2023 Nov; 14(11):753. PubMed ID: 37980415
[TBL] [Abstract][Full Text] [Related]
18. Clinical phenotypes combined with saturation genome editing identifying the pathogenicity of BRCA1 variants of uncertain significance in breast cancer.
Wan Q; Hu L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xu Y; Xie Y
Fam Cancer; 2021 Apr; 20(2):85-95. PubMed ID: 32803532
[TBL] [Abstract][Full Text] [Related]
19. Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.
Biswas K; Das R; Eggington JM; Qiao H; North SL; Stauffer S; Burkett SS; Martin BK; Southon E; Sizemore SC; Pruss D; Bowles KR; Roa BB; Hunter N; Tessarollo L; Wenstrup RJ; Byrd RA; Sharan SK
Hum Mol Genet; 2012 Sep; 21(18):3993-4006. PubMed ID: 22678057
[TBL] [Abstract][Full Text] [Related]
20. High-throughput functional evaluation of BRCA2 variants of unknown significance.
Ikegami M; Kohsaka S; Ueno T; Momozawa Y; Inoue S; Tamura K; Shimomura A; Hosoya N; Kobayashi H; Tanaka S; Mano H
Nat Commun; 2020 May; 11(1):2573. PubMed ID: 32444794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]